Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: a double-blind, baseline-controlled trial.
Schrempf W, Fauser M, Wienecke M, Brown S, Maaß A, Ossig C, Otto K, Brandt MD, Löhle M, Schwanebeck U, Graehlert X, Reichmann H, Storch A.
Schrempf W, et al.
Eur J Neurol. 2018 Apr;25(4):672-679. doi: 10.1111/ene.13567. Epub 2018 Feb 27.
Eur J Neurol. 2018.
PMID: 29322594
Clinical Trial.
RESULTS: A total of 20 of 30 patients were randomized to rasagiline (mean SD age, 69.9 6.9 years; 10 male; Hoehn-Yahr stage, 1.9 0.8). Compared with baseline, sleep maintenance was significantly increased at the end of the treatment period (relative change normalized to ba …
RESULTS: A total of 20 of 30 patients were randomized to rasagiline (mean SD age, 69.9 6.9 years; 10 male; Hoehn-Yahr stage, 1.9 0.8) …